SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy-MedSci.cn

SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy

Grebely, J; Jacobson, IM; Kayali, Z; Verna, EC; Shiffman, ML; Hyland, RH; Stamm, LM; Huang, KC; Brainard, DM; McHutchison, JG; Pol, S; Chung, RT; Bernstein, DE; Dore, G

JOURNAL OF HEPATOLOGY, 2017; 66 (1): S513

科室
- - 订阅+
  - 更多科室
工具
服务